← Open Payments lookup

KIMBERLY SCHROCK: Open Payments

NPI 1053745729 · HUTCHINSON, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,870 in 99 payments from 18 companies in 2025. Trend: 2023 $997 · 2024 $2,022 · 2025 $1,870

Food & beverage: $1,778Education: $91
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP10$251
Regeneron Healthcare Solutions, Inc.22$194
Genentech USA, Inc.7$181
GlaxoSmithKline, LLC.11$176
CSL Behring8$172
Takeda Pharmaceuticals U.S.A., Inc.7$162
Pharming Healthcare, Inc.7$130
Novartis Pharmaceuticals Corporation6$116
BioCryst US Sales Co., LLC3$99
Amgen Inc.4$83

Products named: DUPIXENT, XOLAIR, FASENRA, RUCONEST, Andembry, OCTAGAM IMMUNE GLOBULIN (HUMAN), ORLADEYO, NUCALA.

Industry payments across KS — which companies pay providers there.